A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors
M. Eyrich et al., A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors, BR J HAEM, 114(2), 2001, pp. 422-432
Transplantation of haematopoietic stem cells from human leucocyte antigen (
HLA)-disparate parental donors presents a promising new approach for the tr
eatment of patients lacking a HLA-matched donor. Success against major obst
acles such as graft-versus-host disease (GvHD) and graft rejection has rece
ntly been demonstrated, so that immune reconstitution is one of the prime f
actors that determines the Ion-term prognosis following transplantation. Tw
enty children transplanted with megadoses of highly purified CD34(+) haemat
opoietic stem cells after rigorous T-cell depletion were prospectively moni
tored for their immune reconstitution during the first post-transplant yean
Natural killer (NK) cells showed a marked increase on d+30. T and B cells
began to reconstitute on d+72 and +68 respectively. During extended follow-
up, their numbers and proliferative capacity upon mitogen stimulation conti
nuaIly increased. Early reconstituting T cells were predominantly of a prim
ed, activated phenotype with severely skewed T-cell receptor (TCR)-repertoi
re complexity. Naive T cells emerged 6 months post transplantation, paralle
led by an increase in TCR-repertoire diversity. All patients self-maintaine
d sufficient immunoglobulin levels after d+200. This study demonstrates tha
t paediatric. recipients of highly purified, haptoidentical stem cells are
able to reconstitute functioning T-, B- and NK-cell compartments within the
first post-transplant yean This, together with the absence of significant
GvHD, provides a strong indication for this approach to be considered in ch
ildren who lack a HLA-matched donor.